Back
Apollo Global Management Vs. NovoCure Industry Stock Comparison
Buy
72
APO
Apollo Global Management
Last Price:
112.06
Seasonality Move:
7.14%
Sell
50
NVCR
NovoCure
Last Price:
14.18
Seasonality Move:
6.82%
Buy
72
Apollo Global Management (APO)
is a Buy
Is Apollo Global Management a Buy, Sell or Hold?
- The current Apollo Global Management [APO] share price is $112.07. The Score for APO is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- APO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $14.19. The Score for NVCR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APO Stock Price Chart
What is Apollo Global Management's stock price today?
-
The Apollo Global Management share price today is $112.07
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APO is experiencing buying pressure, which is a positive indicator for future bullish movement.
APO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 53.28 | Buy |
| Chaikin Money Flow: | 3220070 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (108.62 - 113.56) | Buy |
| Bollinger Bands (100): | (97.1 - 112.82) | Buy |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.36 | Sell |
| Relative Strength Index (14 RSI): | 57.95 | Buy |
| Chaikin Money Flow: | 1387557 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.19 - 14.51) | Buy |
| Bollinger Bands (100): | (12.92 - 15.46) | Sell |
APO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 111.22 | Buy |
| 20-day SMA: | 110.91 | Buy |
| 50-day SMA: | 111.13 | Buy |
| 200-day SMA: | 95.5 | Buy |
| 8-day EMA: | 110.44 | Buy |
| 20-day EMA: | 110.7 | Buy |
| 50-day EMA: | 109.57 | Buy |
| 200-day EMA: | 96.6 | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.65 | Buy |
| 20-day SMA: | 12.98 | Buy |
| 50-day SMA: | 14.2 | Sell |
| 200-day SMA: | 17.13 | Sell |
| 8-day EMA: | 12.89 | Buy |
| 20-day EMA: | 13.04 | Buy |
| 50-day EMA: | 13.72 | Buy |
| 200-day EMA: | 22.25 | Sell |
Apollo Global Management Earnings Growth & APO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.14 per share, an increase this year of $1.12 per share, and an increase next year of $1.31 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.63 per share, and a decrease next year of $0.41 per share.
Apollo Global Management Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||